Developing Potent Compounds
When developing and manufacturing different Pharmaceutical products that are produced in the same facilities, the potential for cross- contamination and safety are a concern. Medicinal products provide a benefit to the intended patient or animal; however as a cross contaminant, they provide no benefit to the patient or animal and may even pose a risk. The presence of such contaminants should be managed according to the risk posed which in turn are related to levels that can be considered safe for all populations and operators.
Download our White Paper to learn how Pii identifies and mitigates risks.